CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in PCVX — Vaxcyte, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in PCVX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$85,149,521
+$3,566,103 QoQ
Shares Held
1,464,812
+4.3% QoQ
Ownership
0.984%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#20
of 329 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. PCVX ranks #21 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in PCVX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $85,149,521 | 1,464,812 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $81,583,418 | 1,403,948 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $59,697,316 | 1,293,830 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $46,588,520 | 1,293,407 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $46,089,784 | 1,417,711 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $50,348,504 | 1,333,382 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $109,837,537 | 1,341,773 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $148,075,293 | 1,295,837 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $66,164,655 | 876,237 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $56,944,445 | 833,618 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $45,871,506 | 730,438 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $36,342,010 | 712,868 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $30,386,991 | 608,470 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $18,276,484 | 487,633 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $23,422,568 | 488,479 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $8,285,424 | 345,226 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,302,718 | 289,647 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $6,334,327 | 262,291 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $5,764,769 | 242,319 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $6,031,666 | 237,748 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $3,885,293 | 172,603 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,689,515 | 136,178 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $3,124,446 | 117,593 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $5,731,289 | 116,065 | Shares | Sole | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||